Literatur
-
1
Hansen E, Knuechel R, Altmeppen J, Taeger K.
Blood irradiation for intraoperative autotransfusion in cancer surgery: demonstration of efficient elimination of contaminating tumor cells.
Transfusion.
1999;
39
608-615
-
2
Biedler A, Wilhelm W.
Erythrozytenqualität nach maschineller Autotransfusion und Wundblutdrainage.
Anaesthesist.
2001;
50 (Suppl 1)
24-29
-
3
Hay S N, Monk T G, Brecher M E.
Intraoperative blood salvage: a mathematical perspective.
Transfusion.
2002;
42
451-455
-
4
Hansen E, Altmeppen J, Marienhagen J, Taeger K.
Quality of blood salvaged and irradiated during cancer surgery.
Transfusion.
1999;
39
S256
-
5
Weisbach V, Hunold I, Zimmermann R, Lutter N, Parsch H, Zingsem J, Glaser A, Eckstein R.
In vitro characteristics of red blood cell concentrates prepared from under- and overcollected units of whole blood and from a pediatric blood bag system.
Transfus Med.
2000;
10
23-30
-
6
Valeri C R, Yarnoz M, Vecchione J J, Dennis R C, Anastasi J, Valeri D A, Pivacek L E, Hechtman H B, Emerson C P, Berger R L.
Improved oxygen delivery to the myocardium during hypothermia by perfusion with 2,3-DPG enriched red blood cells.
Ann Thorac Surg.
1980;
30
527-535
-
7
Vamvakas E C, Carven J H.
Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells.
Transfusion.
1999;
39
701-710
-
8
Vamvakas E C, Carven J H.
Length of storage of transfused red cells and postoperative morbidity in patients undergoing coroinary artery bypass graft surgery.
Transfusion.
2000;
40
101-109
-
9
Vamvakas E C.
Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials.
Transfusion.
1996;
36
175-186
-
10
Vamvakas E C, Blajchman M A.
Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?.
Blood.
2001;
97
1180-1195
-
11
Jacobi K E, Wanke C, Jacobi A, Weisbach V, Hemmerling T M.
Determination of eicosanoid and cytokine production in salvaged blood, stored red blood cell concentrates, and whole blood.
J Clin Anesth.
2000;
12
94-99
-
12
Vamvakas E C.
Meta-analysis of randomized controlled trials comparing the risk of postoperative infection between recipients of allogeneic and autologous blood transfusion.
Vox Sang.
2002;
83
339-346
-
13
Nash G F, Chopada A, Patel H, Kakkar A K.
Stored blood products stimulate cancer growth.
Br J Surg.
2002;
89 Suppl 1
19
-
14
Wollinsky K H, Mehrkens H H, Geiger P, Weindler M, Waltera S U, Grimm H.
Kinetics of bacterial wash-out in the Haemonetics Cell Saver III.
Beitr Infusionsther.
1991;
28
337-340
-
15
Reents W, Babin-Ebell J, Misoph M R, Schwarzkopf A, Elert O.
Influence of different autotransfusion devices on the quality of salvaged blood.
Ann Thorac Surg.
1999;
68
58-62
-
16
Bland L A, Villarino M E, Arduino M J, McAllister S K, Gordon S M, Uyeda C T, Valdon C, Potts D, Jarvis W R, Favero M S.
Bacteriologic and endotoxin analysis of salvaged blood used in autologous transfusions during cardiac operations.
J Thorac Cardiovasc Surg.
1992;
103
582-588
-
17
Faris P M, Ritter M A, Keating E M, Valeri C R.
Unwashed filtered shed blood collected after knee and hip arthroplasties. A source of autologous red blood cells.
J Bone Joint Surg Am.
1991;
73
1169-1178
-
18 Carless P A, Henry D A, Moxey A J, O’Connell D L, Fergusson D A. Cell salvage for minimising perioperative allogeneic blood transfusion (Cochrane Review). In: The Cochrane Library, Issue 4. Chichester, UK; John Wiley & Sons, Ltd 2003
-
19 Deutsch E, Bender A, Eckstein R, Zimmerman R. Transfusionsrecht. Stuttgart; Wissenschaftliche Verlagsgesellschaft mbH 2001
-
20 Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz - AMG) vom 24. 8. 1976 (BGBl. I S. 2445), in der Neufassung durch Bekanntmachung vom 11. 12. 1998 (BGBl. I S. 3586).
-
21 Seitz R. Persönliche Mitteilung, Paul-Ehrlich-Institut, 2000.
-
22 Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Köln; Deutscher Ärzte-Verlag 2001
-
23 Verordnung über den Schutz vor Schäden durch ionisierenden Strahlen (StrlSchV - Strahlenschutzverordnung) vom 20. 7. 2001 (BGBl. I Nr. 38 vom 26. 7. 2001).
-
24
Baele P L, de Bruyere M, Deneys V, Dupont E, Flament J, Lambermont M, Latinne D, Steensens L, van Camp B, Waterloos H.
Bedside transfusion errors. A prospective survey by the Belgium SAnGUIS Group.
Vox Sang.
1994;
66
117-121
-
25 Leitlinien zur Therapie mit Blutkomponenten und Plasmaderivaten. 3. überarbeitete und erweiterte Auflage. Köln; Deutscher Ärzte-Verlag 2003
PD Dr. Volker Weisbach
Abteilung für Transfusionsmedizin und Hämostaseolgie · Universitätsklinikum Erlangen
Krankenhausstraße 12 · 91054 Erlangen
Email: Volker.Weisbach@trans.imed.uni-erlangen.de
